Relates to health insurance coverage for in vitro fertilization.
Impact
If passed, A08349 would directly impact how health insurance companies in New York are required to provide coverage for IVF. Specifically, the bill prohibits insurers from requiring the transfer of all embryos from a prior cycle as a condition for coverage of subsequent cycles for women aged thirty-five and older. This change is expected to reduce unnecessary hurdles for women who wish to pursue fertility treatments, thereby increasing their chances of successful conception.
Summary
Bill A08349 seeks to amend the insurance law regarding health insurance coverage for in vitro fertilization (IVF). The legislative intent is to enhance access to fertility treatments by ensuring that insurance providers cannot discriminate against individuals based on certain health conditions or personal characteristics, such as age, sex, sexual orientation, marital status, or gender identity. This amendment aims to create a more inclusive healthcare environment for those seeking IVF services.
Contention
While proponents of A08349 argue that it will expand essential healthcare access and support family planning, there may be some contention surrounding the cost implications for insurance providers. Critics might raise concerns about the potential financial burden on insurers and, consequently, on policyholders. Additionally, the bill's stipulations regarding non-discrimination might provoke debates about how broadly or narrowly these protections should be interpreted within the context of other health laws.
Expands insurance coverage for in vitro fertilization; includes coverage under individual policies; provides coverage for three complete oocyte retrievals and in vitro fertilization with unlimited embryo transfers.
Expands insurance coverage for in vitro fertilization; includes coverage under individual policies; provides coverage for three complete oocyte retrievals and in vitro fertilization with unlimited embryo transfers.
Creates an in vitro fertilization treatment tax credit for up to three cycles of in vitro fertilization treatment for expenses related to treatment for infertility.
Creates an in vitro fertilization treatment tax credit for up to three cycles of in vitro fertilization treatment for expenses related to treatment for infertility.